PRODUCT CLASSIFICATION:
Glycoprotein Cytokine
ACNE:
None
WATER RETENTION:
None
HBR:
None
HEPATOTOXICITY:
None
AROMATIZATION:
None
MANUFACTURER:
Drogsan
WAREHOUSE LOCATION:
International Warehouse 2
ACTIVE SUBSTANCE:
Erythropoietin
Introducing Dropoetin, a clinically approved treatment for anemia associated with chronic renal failure in both pediatric and adult patients undergoing hemodialysis and peritoneal dialysis. This versatile medication is designed to effectively manage severe renal-origin anemia in adults exhibiting clinical symptoms, even before they start dialysis.
Dropoetin is also an essential option for adult cancer patients (excluding those with myeloid malignancies) undergoing chemotherapy, as it helps treat anemia and reduces the need for transfusions. Additionally, it is beneficial for adults with HIV who are on zidovudine and have endogenous Dropoetin levels of ?500 mU/ml.
For adults, Dropoetin supports autologous blood collection in predeposit programs, minimizing the need for allogeneic blood transfusions in patients with moderate anemia (hematocrit levels of 33-39%, hemoglobin between 10-13 g/dL) who are scheduled for major elective surgeries. This treatment is particularly recommended when substantial blood volume (4+ units for females, 5+ units for males) is anticipated and blood-saving methods are inadequate.
Furthermore, Dropoetin enhances erythropoiesis during the perisurgical period, reducing the need for allogeneic blood transfusions and addressing postoperative anemia in adults with moderate anemia (e.g., Hb 10-13 g/dL) who face expected moderate blood loss (900 to 1800 ml) during major orthopedic surgeries.
Dropoetin is also indicated for treating anemia in patients diagnosed with Low or Intermediate 1-risk Myelodysplastic Syndrome (MDS), specifically for those with hemoglobin levels below 10 g/dL.
How to Use Dropoetin:
Administer Dropoetin precisely as prescribed by your healthcare provider. Always consult the medication label for detailed dosing instructions.
Included with Dropoetin is a Medication Guide for patients?review it thoroughly and refer to it each time you refill your prescription. Typically, Dropoetin is given as an injection by a healthcare professional in a clinical environment. If you will be using it at home, a healthcare provider will demonstrate the proper administration techniques. Ensure you fully understand how to use Dropoetin and follow all provided guidance. If you have any questions, don?t hesitate to contact your provider.
When preparing your dose, adhere to the method shown to you to avoid contamination of the vial, syringe, or medication. Avoid touching the rubber stopper of the vial or the syringe needle with your fingers.
Before administration, double-check that you have the correct dose ready. Do not shake Dropoetin or use it if it has been shaken or frozen. Avoid diluting or mixing Dropoetin with other solutions unless directed by your doctor. Dispose of any remaining medication from single-dose vials after administration, and consult your healthcare provider with any questions regarding single-dose vials.
Do not use Dropoetin if it appears cloudy, discolored, contains particles, or if the vial is cracked or damaged. Keep Dropoetin, along with syringes and needles, out of reach of children and pets. Never reuse needles or syringes; follow your healthcare provider?s advice on proper disposal methods and adhere to local regulations.
Continue your Dropoetin regimen as prescribed, even if you feel well, and do not skip doses. If you miss a dose, contact your doctor immediately.
For any inquiries regarding Dropoetin, feel free to reach out to your healthcare provider.
Possible Side Effects of Dropoetin:
Serious adverse reactions are outlined in other sections of the label, including:
- Increased mortality due to myocardial infarction, stroke, and thromboembolism
- Heightened risk of tumor progression or recurrence in cancer patients
- Hypertension
- Seizures
- Pure Red Cell Aplasia (PRCA)
- Severe allergic reactions